Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer
- PMID: 21724118
- DOI: 10.1016/j.clinimag.2010.07.010
Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer
Abstract
The role of carcinoembryonic antigen (CEA), magnetic resonance imaging (MRI), and positron emission tomography (PET)-computed tomography (CT) in detection of local recurrence of colorectal cancer is evaluated in 71 patients, selected due to suspected relapse at CT follow-up. Recurrence was confirmed by histology in 18 cases and excluded in 25 cases. Sensitivity, specificity, positive and negative predictive values, and accuracy were as follows: 44.4%, 92.5%, 66.7%, 83.1%, and 80.3% for CEA; 88.9%, 73.6%, 53.3%, 95.1%, and 77.5% for MRI; and 94.4%, 73.6%, 54.8%, 97.5%, and 78.9% for PET-CT. A diagnostic protocol integrating CEA and dedicated imaging studies is to be advocated.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.Dis Colon Rectum. 2009 Feb;52(2):253-9. doi: 10.1007/DCR.0b013e31819d11e6. Dis Colon Rectum. 2009. PMID: 19279420
-
Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.AJR Am J Roentgenol. 2010 Mar;194(3):766-71. doi: 10.2214/AJR.09.3205. AJR Am J Roentgenol. 2010. PMID: 20173157
-
Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.Neoplasma. 2017;64(6):954-961. doi: 10.4149/neo_2017_613. Neoplasma. 2017. PMID: 28895416
-
PET imaging for evaluation of metastatic colorectal cancer of the liver.Eur J Radiol. 2006 May;58(2):229-35. doi: 10.1016/j.ejrad.2005.11.042. Epub 2006 Feb 2. Eur J Radiol. 2006. PMID: 16457980 Review.
-
Established, emerging and future roles of PET/CT in the management of colorectal cancer.Clin Radiol. 2009 Mar;64(3):225-37. doi: 10.1016/j.crad.2008.08.008. Epub 2008 Oct 23. Clin Radiol. 2009. PMID: 19185652 Review.
Cited by
-
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.Oncologist. 2016 Dec;21(12):1502-1508. doi: 10.1634/theoncologist.2016-0222. Epub 2016 Oct 14. Oncologist. 2016. PMID: 27742904 Free PMC article.
-
Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer.Nucl Med Mol Imaging. 2013 Sep;47(3):181-7. doi: 10.1007/s13139-013-0218-4. Epub 2013 Aug 6. Nucl Med Mol Imaging. 2013. PMID: 24900105 Free PMC article.
-
Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).Oncotarget. 2017 Mar 28;8(13):21639-21649. doi: 10.18632/oncotarget.15452. Oncotarget. 2017. PMID: 28423493 Free PMC article.
-
Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.World J Gastroenterol. 2014 Jun 7;20(21):6608-14. doi: 10.3748/wjg.v20.i21.6608. World J Gastroenterol. 2014. PMID: 24914384 Free PMC article.
-
Clinical Etiology of Hypermetabolic Pelvic Lesions in Postoperative Positron Emission Tomography/Computed Tomography for Patients With Rectal and Sigmoid Cancer.Ann Coloproctol. 2018 Apr;34(2):78-82. doi: 10.3393/ac.2017.09.21. Epub 2018 Apr 30. Ann Coloproctol. 2018. PMID: 29742861 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical